Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts ...

Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to ...

The sudden departure of Peter Marks, MD, from the FDA has prompted a chorus of criticism and despair from industry leaders and trade organizations.

Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.

Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.

Recently a reader shared with me their concern about the aging process. They were not happy with the changes in their body, despite exercising regularly. With the accumulation of more and more ...

Marks offered his resignation while citing Kennedy’s “misinformation and lies” and an “unprecedented assault on scientific ...

Gene therapy maker bluebird bio said on Friday it had received a non-binding offer from peer Ayrmid for up to $110.5 million, sending its shares up 9.8% at $4.40 in extended trading.

The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has announced the ...

Frederick L. Locke, MD, discussed cema-cel's safety, efficacy, and potential for treating large B-cell lymphoma in earlier ...

Spread the love Introduction The biotechnology industry continues to be at the forefront of scientific innovation, driving ...

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more ...